Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
TME PHARMA CEO MESSAGE
Berlin, Germany, September 16, 2026, 8.00am CET – TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company specializing in the development of novel therapies for brain cancer and eye diseases, today publishes a…
Piramal Pharma Solutions Advances Sustainability Efforts with Solar Power Plant Addition at Morpeth, UK Site
Piramal Pharma Solutions is installing a ground-mounted solar power plant (4.3 MWp) at its integrated drug substance and drug product site in Morpeth, UK. The new plant will provide renewable energy directly to the site through a behind-the-meter…
Watch live: Trump's pick for surgeon general faces Senate confirmation hearing
Dr. Nicole Saphier, whom President Trump tapped to serve as U.S. surgeon general, will testify before the Senate Health, Education, Labor and Pensions Committee on Wednesday morning. Saphier, a media personality, was the third person Trump picked…
Blood Cancer United Announces $7.5 Million Gift From Royalty Pharma to Expand Therapy Acceleration Program
The donation marks a new phase for TAP, with Royalty Pharma serving as the first and largest corporate donor under an updated model that invites direct donations to the program. TAP donations are deployed as venture capital investments in…
Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler
Aurobindo Pharma has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg. The product is a generic equivalent of QVAR…
NewAmsterdam Pharma (NASDAQ:NAMS) Reaches New 12-Month Low - Here's Why
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) reached a new 52-week low during trading on Wednesday. The stock traded as low as $21.08 and last traded at $21.16, with a volume of 1732731 shares trading hands. The stock had…
BridgeBio Pharma (NASDAQ:BBIO) Trading Down 6.4% - Here's Why
Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) were down 6.4% on Tuesday. The stock traded as low as $69.17 and last traded at $67.77. 911,774 shares were traded during mid-day trading, a decline of 68% from the average session…
Insider Buying: NewAmsterdam Pharma (NASDAQ:NAMS) CEO Acquires 10,000 Shares of Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CEO Michael Davidson acquired 10,000 shares of NewAmsterdam Pharma stock in a transaction on Monday, September 14th. The stock was purchased at an average cost of $22.65 per share…
Avalyn Pharma (NASDAQ:AVLN) Shares Gap Up - Should You Buy?
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report)'s share price gapped up prior to trading on Tuesday. The stock had previously closed at $33.57, but opened at $35.01. Avalyn Pharma shares last traded at $34.46, with a volume of 5,918 shares…
Moscow and Delhi Expand Investment and Industrial Cooperation
A Moscow government delegation held around 200 meetings with Indian officials, business associations and companies during a visit to India, according to Anatoly Garbuzov, Moscow Government Minister and head of the city's Department of Investment…
Show me the receipts!': Warren grills RFK Jr. aide on drug pricing deals
“Show me the receipts!” Warren said during her heated exchange with Klomp. “Why are you hiding these contracts?” The MFN deals, which promise to lower prescription drug prices in the United States to match those in other…
Lonza Group AG (LZAGY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Lonza Group AG (LZAGY) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 10:45 AM EDT Philippe Deecke - Chief Financial Officer Thibault Boutherin - Morgan Stanley, Research Division Morgan Stanley, Research Division So…
My Top 5 Favorite Stocks for an Uncertain Market
The S&P 500 has climbed this year, adding to three consecutive years of gains. But with levels near record highs, valuations relatively high, and concerns about artificial intelligence (AI) spending and rising inflation brewing, some investors have…
Neagley review - this violent Reacher spinoff is a glorious hour off from normal life
Neagley. It's pronounced “Neely” but after that, honestly, it's very simple. Neagley is Frances Neagley, Jack Reacher's friend and former colleague in Reacher (pronounced “Reacher”, though as rarely as possible for our…
Healthpeak Properties: Outpatient And Senior Portfolio Shows Proven Performance
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Receive a Daily briefing on Pharma Industry News
Get Started